Press Release

Limerston Capital Backed Cormica Announces First US Acquisition With New Jersey Based TPM Laboratories

Seven-figure purchase underlines ambitions to be a global leader UK-based medical device and pharmaceuticals testing group, Cormica, has completed the seven-figure purchase of TPM Laboratories (TPM) in New Jersey. Cormica, which is backed by Limerston Capital, a UK mid-market private equity investment firm, is focused on strategically expanding its capabilities across the US and Europe.  

Cormica Bradford Expands Testing Capabilities with State-of-the-Art Equipment

Cormica Bradford Expands Testing Capabilities with State-of-the-Art Equipment

Cormica Bradford Expands Testing Capabilities with State-of-the-Art Equipment Type: Published: Authors: Caroline GermanTechnical DirectorCormica Bradford Cormica Bradford, a division of Cormica known for its unwavering commitment to enhancing patient lives through comprehensive testing services, is proud to announce a significant expansion of its laboratory capabilities. This investment is a strategic step in supporting key client

Concept Life Sciences transfers Bradford business to Cormica

This Deal will maximise synergies and sharpen focus on growth areas Leading integrated drug discovery, development and manufacturing organisation, Concept Life Sciences has carved out its Bradford analytical chemistry business to Cormica the specialists in testing services for medical device and pharmaceutical manufacturers. Both Concept Life Sciences and Cormica are part of private equity house,

Scroll to Top